Nichi-Iko to acquire Sagent for $736m

13-07-2016

Nichi-Iko Pharmaceutical, a Tokyo-based drugs company, will acquire Illinois-based Sagent Pharmaceuticals for $736 million in cash.


Nichi-Iko, Sagent, mergers and acquisition, generic drugs, biosimilars

LSIPR